Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
COVID-19 coagulopathy: from pathogenesis to treatment
T Alnima, MMG Mulder, BCT van Bussel… - Acta …, 2022 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of
2019 and continues to exert an unfavorable worldwide health impact on a large proportion …
2019 and continues to exert an unfavorable worldwide health impact on a large proportion …
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
Arterial and venous thrombotic events in COVID-19 cause significant morbidity and mortality
among patients. Although international guidelines agree on the need for anticoagulation, it …
among patients. Although international guidelines agree on the need for anticoagulation, it …
[HTML][HTML] The role of heparin in COVID-19: An update after two years of pandemics
M Mangiafico, A Caff, L Costanzo - Journal of Clinical Medicine, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous
thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial …
thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial …
[HTML][HTML] Venous thromboembolic disease in COVID-19, pathophysiology, therapy and prophylaxis
M Dybowska, D Wyrostkiewicz, L Opoka… - International journal of …, 2022 - mdpi.com
For over two years, the world has been facing the epidemiological and health challenge of
the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute …
the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute …
COVID-19 patients with acute pulmonary embolism have a higher mortality risk: systematic review and meta-analysis based on Italian cohorts
Background Acute pulmonary embolism has been recognized as a frequent complication of
COVID-19 infection influencing the clinical course and outcomes of these patients …
COVID-19 infection influencing the clinical course and outcomes of these patients …
COVID-19 and cardiovascular disease in patients with chronic kidney disease
L Del Vecchio, O Balafa, E Dounousi… - Nephrology Dialysis …, 2024 - academic.oup.com
Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …
The effect of heparin full-dose anticoagulation on survival of hospitalized, non-critically Ill COVID-19 patients: a meta-analysis of high quality studies
Background International COVID-19 guidelines recommend thromboprophylaxis for non-
critically ill inpatients to prevent thrombotic complications. It is still debated whether full-dose …
critically ill inpatients to prevent thrombotic complications. It is still debated whether full-dose …
Population pharmacokinetics and probability of target attainment analysis of nadroparin in different stages of COVID-19
Abstract Background and Objective The risk of thrombotic complications in critical patients
with COVID-19 remains extremely high, and multicenter trials failed to prove a survival …
with COVID-19 remains extremely high, and multicenter trials failed to prove a survival …
Continuation of therapeutic dose heparin for critically ill patients with COVID-19
Randomized trials demonstrated improved clinical outcomes when therapeutic-dose
heparin is administered to non-critically ill patients hospitalized for coronavirus disease …
heparin is administered to non-critically ill patients hospitalized for coronavirus disease …
Anticoagulation in COVID-19 patients–An updated systematic review and meta-analysis
S Reis, A Faske, I Monsef, F Langer, OJ Müller… - Thrombosis …, 2024 - Elsevier
Background Thromboembolic events are common complications of COVID-19. Clinical study
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …